This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the delivery of 4567190755 ANTI-B BIOCLONE 15X10ML, a critical medical diagnostic product. It is a fixed price delivery order with economic price adjustment, with a completion date of February 12, 2025. No set-aside designation was used, indicating open competition....
This is a $1,832.54 delivery order awarded by the Medical Supply Chain, a division of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the supply of "ANTI-A BIOCLONE 15X10ML", a medical diagnostic product, with a period of performance through May 2025. The contract has a fixed price with economic price adjustment pricing type and does not utilize any set-aside designations. Ortho-Clinical Diagnostics, Inc. is a...
This is a delivery order awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense agency. The contract has a ceiling value of $1,832.54 and is for the delivery of ANTI-B BIOCLONE 15X10ML medical supplies. It is a fixed-price contract with economic price adjustment and does not have any set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture...
This is a federal contract award from the Medical Supply Chain (an alternate name for the Defense Agency), valued at $1,305.93, awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is a Delivery Order, with a fixed price and economic price adjustment pricing type, and an ultimate completion date of June 20, 2025. It does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that specializes...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the delivery of anti-A bioclone 15x10ml. The contract was awarded by the Medical Supply Chain, a component of the Defense agency, and has a ceiling value of $1,832.54. The contract is a Delivery Order with a fixed price and economic price adjustment pricing type, and has an ultimate completion date of April 28, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The contract is for the delivery of ANTI-A BIOCLONE 15X10ML, a medical product. The contract does not have a set-aside designation and was awarded on a competitive basis. Ortho-Clinical Diagnostics, Inc. has previously provided various medical equipment, reagents, consumables, and...
This federal contract award, valued at $2,072.88, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc. for the delivery of ANTI-A BIOCLONE 15X10ML medical supplies. The contract was awarded as a fixed price with economic price adjustment delivery order, without any set-aside designation. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including reagents, test kits, and clinical...
This is a federal delivery order contract awarded by the Medical Supply Chain, a division of the Defense Logistics Agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract, valued at $1,832.54, is for the delivery of ANTI-A BIOCLONE 15X10ML medical supplies. The contract has a fixed price with economic price adjustment pricing structure and an ultimate completion date of August 29, 2024. There is no set-aside designation mentioned in the...
This is a $1,767.32 fixed-price delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer registered in SAM.gov as a self-certified HUBZone joint venture. The contract is for the supply of anti-A,B bioclone laboratory reagents, with a period of performance through February 2025. Ortho-Clinical Diagnostics has demonstrated the capability to provide critical medical diagnostic...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, to provide anti-A bioclone 15x10mL to a U.S. government agency. The contract has a ceiling value of $1,497.37 and is a delivery order with a fixed price and economic price adjustment. The ultimate completion date is February 28, 2025, and the award date is February 25, 2025. The contract does not have a set-aside designation, indicating open competition. The awarding agency is the...